PL2433637T3 - Zastosowanie pochodnych kwinazoliny w chorobach neurodegeneracyjnych - Google Patents
Zastosowanie pochodnych kwinazoliny w chorobach neurodegeneracyjnychInfo
- Publication number
- PL2433637T3 PL2433637T3 PL10732398T PL10732398T PL2433637T3 PL 2433637 T3 PL2433637 T3 PL 2433637T3 PL 10732398 T PL10732398 T PL 10732398T PL 10732398 T PL10732398 T PL 10732398T PL 2433637 T3 PL2433637 T3 PL 2433637T3
- Authority
- PL
- Poland
- Prior art keywords
- neurodegenerative diseases
- quinazoline derivatives
- quinazoline
- derivatives
- neurodegenerative
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200930189A ES2353093B1 (es) | 2009-05-20 | 2009-05-20 | Uso de derivados de quinazolinas y sus composiciones farmacéuticas en enfermedades neurodegenerativas. |
PCT/ES2010/070338 WO2010133742A1 (es) | 2009-05-20 | 2010-05-20 | Uso de derivados de quinazolinas en enfermedades neurodegenerativas |
EP10732398.2A EP2433637B9 (en) | 2009-05-20 | 2010-05-20 | Use of quinazoline derivatives for neurodegenerative diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2433637T3 true PL2433637T3 (pl) | 2014-12-31 |
Family
ID=42732572
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL10732398T PL2433637T3 (pl) | 2009-05-20 | 2010-05-20 | Zastosowanie pochodnych kwinazoliny w chorobach neurodegeneracyjnych |
Country Status (10)
Country | Link |
---|---|
US (1) | US9192610B2 (pl) |
EP (1) | EP2433637B9 (pl) |
JP (1) | JP5563068B2 (pl) |
AU (1) | AU2010251044B2 (pl) |
DK (1) | DK2433637T5 (pl) |
ES (2) | ES2353093B1 (pl) |
PL (1) | PL2433637T3 (pl) |
PT (1) | PT2433637E (pl) |
SI (1) | SI2433637T1 (pl) |
WO (1) | WO2010133742A1 (pl) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT2118074E (pt) | 2007-02-01 | 2014-03-20 | Resverlogix Corp | Compostos para a prevenção e tratamento de doenças cardiovasculares |
CA3146333A1 (en) | 2009-03-18 | 2010-09-23 | Resverlogix Corp. | Phenyl-quinazolin-4(3h)-one and phenyl-pyrido[2,3-d]pyrimidin-4(3h)-one derivatives and compositions thereof useful as anti-inflammatory agents |
WO2016147053A1 (en) | 2015-03-13 | 2016-09-22 | Resverlogix Corp. | Compositions and therapeutic methods for the treatment of complement-associated diseases |
ES2544519B1 (es) * | 2015-05-22 | 2016-03-04 | Consejo Superior De Investigaciones Científicas (Csic) | Quinazolinas S-sustituidas y sus aplicaciones terapéuticas para el tratamiento de enfermedades mediadas por PDE7 |
EP3313836B1 (en) | 2015-06-26 | 2020-11-11 | Takeda Pharmaceutical Company Limited | 2,3-dihydro-4h-1,3-benzoxazin-4-one derivatives as modulators of cholinergic muscarinic m1 receptor |
BR112018006873A2 (pt) | 2015-10-05 | 2018-11-06 | The Trustees Of Columbia University In The City Of New York | ativadores do fluxo autofágico e fosfolipase d e depuração de agregados de proteína incluindo tau e tratamento de proteinopatias |
JP6787913B2 (ja) * | 2015-10-20 | 2020-11-18 | 武田薬品工業株式会社 | 複素環化合物 |
JP2022547707A (ja) * | 2019-09-12 | 2022-11-15 | ディスアーム セラピューティクス, インコーポレイテッド | Sarm1の阻害剤 |
WO2024038090A1 (en) | 2022-08-18 | 2024-02-22 | Mitodicure Gmbh | Use of substituted benzoxazole and benzofuran compounds for the treatment and prevention of diseases associated with chronic fatigue, exhaustion and/or exertional intolerance |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07107056B2 (ja) * | 1987-01-30 | 1995-11-15 | 日清製粉株式会社 | 4(3h)−キナゾリノン誘導体、その製造方法およびそれを有効成分とする抗潰瘍剤 |
FR2828693B1 (fr) * | 2001-08-14 | 2004-06-18 | Exonhit Therapeutics Sa | Nouvelle cible moleculaire de la neurotoxicite |
US20050038051A1 (en) * | 2003-06-09 | 2005-02-17 | Jodi Nunnari | Novel molecules for regulating cell death |
ES2308916B1 (es) * | 2007-03-22 | 2009-10-29 | Consejo Superior De Investigaciones Cientificas | Compuesto inhibidor dual de las enzimas pde7 y/o pde4, composiciones farmaceuticas y sus aplicaciones. |
MX2009010450A (es) | 2007-03-27 | 2009-11-23 | Omeros Corp | El uso de inhibidores de la fosfodiesterasa 7 para el tratamiento transtornos del movimiento. |
US20100179158A1 (en) * | 2007-04-20 | 2010-07-15 | Hoffman Charles S | Inhibitors of cyclic amp phosphodiesterases |
-
2009
- 2009-05-20 ES ES200930189A patent/ES2353093B1/es not_active Expired - Fee Related
-
2010
- 2010-05-20 SI SI201030690T patent/SI2433637T1/sl unknown
- 2010-05-20 PL PL10732398T patent/PL2433637T3/pl unknown
- 2010-05-20 JP JP2012511311A patent/JP5563068B2/ja not_active Expired - Fee Related
- 2010-05-20 EP EP10732398.2A patent/EP2433637B9/en active Active
- 2010-05-20 WO PCT/ES2010/070338 patent/WO2010133742A1/es active Application Filing
- 2010-05-20 PT PT107323982T patent/PT2433637E/pt unknown
- 2010-05-20 ES ES10732398.2T patent/ES2498828T3/es active Active
- 2010-05-20 DK DK10732398.2T patent/DK2433637T5/da active
- 2010-05-20 US US13/321,046 patent/US9192610B2/en not_active Expired - Fee Related
- 2010-05-20 AU AU2010251044A patent/AU2010251044B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
US20120129877A1 (en) | 2012-05-24 |
JP2012527434A (ja) | 2012-11-08 |
WO2010133742A1 (es) | 2010-11-25 |
AU2010251044B2 (en) | 2014-08-28 |
ES2353093B1 (es) | 2012-01-03 |
EP2433637B1 (en) | 2014-06-11 |
SI2433637T1 (sl) | 2014-09-30 |
ES2498828T3 (es) | 2014-09-25 |
EP2433637B9 (en) | 2015-06-10 |
PT2433637E (pt) | 2014-09-09 |
DK2433637T3 (en) | 2014-08-18 |
AU2010251044A1 (en) | 2012-03-01 |
DK2433637T5 (da) | 2015-08-31 |
US9192610B2 (en) | 2015-11-24 |
JP5563068B2 (ja) | 2014-07-30 |
ES2353093A1 (es) | 2011-02-25 |
EP2433637A1 (en) | 2012-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL237581B (en) | Derivatives of 6-oxo-pyrazinopyrrolopyrimidines | |
GB0910003D0 (en) | Novel compounds for the treatment of neurodegenerative diseases | |
IL219073A (en) | A drug combination for cancer treatment | |
PL2433637T3 (pl) | Zastosowanie pochodnych kwinazoliny w chorobach neurodegeneracyjnych | |
IL221132A0 (en) | Derivatives of betulin | |
GB201021103D0 (en) | New compounds for the treatment of neurodegenerative diseases | |
SG10201507120TA (en) | Treatment of diseases | |
IL214746A0 (en) | Substituted pyrimidines for the treatment of cancer | |
EP2613786A4 (en) | TREATMENT OF DISEASES | |
HRP20130538T1 (en) | Therapeutic uses of quinazolinedione derivatives | |
HK1166472A1 (en) | Treatment of dyskinesia related disorders | |
GB0906159D0 (en) | Drug combination for the treatment of proteostatic diseases | |
IL201449A0 (en) | Heteroarylamide-substituted pyrimidone derivatives for the treatment of neurodegenerative diseases | |
EP2427183A4 (en) | THERAPEUTIC COMPOUNDS | |
GB2468936B (en) | Chlorination of sucrose-6-esters | |
EP2400848A4 (en) | CRYSTALLIZATION OF PHARMACEUTICAL COMPOUNDS | |
IL241253A0 (en) | Peptides for the treatment of neurodegenerative diseases | |
IL219872A0 (en) | Quinazoline derivatives | |
EP2496704A4 (en) | THERAPEUTIC COMPOUNDS | |
GB201012926D0 (en) | Compounds for treatment of inflammation | |
ZA201202379B (en) | Antagonists of dsgs2 for treatment of cancer | |
EP2478359A4 (en) | METHOD FOR IDENTIFYING ANTI-INFLAMMATORY COMPOUNDS | |
HK1131039A1 (en) | Pharmaceutical use of sophoricoside | |
EP2456309A4 (en) | THERAPEUTIC COMPOUNDS | |
GB0906026D0 (en) | Therapeutic compounds |